Hims & Hers Health (HIMS) Insider Trading & Ownership $49.10 -17.32 (-26.07%) Closing price 03:59 PM EasternExtended Trading$49.00 -0.09 (-0.19%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Hims & Hers Health (NYSE:HIMS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.71%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$2.08 MNumber OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$89.56 M Get HIMS Insider Trade Alerts Want to know when executives and insiders are buying or selling Hims & Hers Health stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HIMS Insider Buying and Selling by Quarter Hims & Hers Health Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/18/2025Andrew DudumCEOSell128,127$58.27$7,465,960.29 2/18/2025Soleil BoughtonInsiderSell4,152$60.69$251,984.88 2/12/2025Melissa BairdCOOSell67,687$44.71$3,026,285.77 2/10/2025Michael ChiInsiderSell7,259$43.28$314,169.52 2/10/2025Oluyemi OkupeCFOSell11,581$43.01$498,098.81 2/4/2025Oluyemi OkupeCFOSell11,581$38.92$450,732.52 2/3/2025Soleil BoughtonInsiderSell4,153$35.30$146,600.90 1/31/2025Andrew DudumCEOSell100,000$35.22$3,522,000.00 1/24/2025Michael ChiInsiderSell17,304$31.00$536,424.00 1/23/2025Andrew DudumCEOSell27,098$30.08$815,107.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/21/2025Andrew DudumCEOSell300$30.00$9,000.00 1/21/2025Melissa BairdCOOSell67,687$29.35$1,986,613.45 1/21/2025Soleil BoughtonInsiderSell54,153$29.90$1,619,174.70 1/16/2025Andrew DudumCEOSell36,460$27.09$987,701.40 1/13/2025Oluyemi OkupeCFOSell11,581$24.44$283,039.64 1/10/2025Michael ChiInsiderSell7,259$24.07$174,724.13 1/6/2025Soleil BoughtonInsiderSell268,932$27.75$7,462,863.00 12/26/2024Oluyemi OkupeCFOSell4,213$29.98$126,305.74 12/24/2024Michael ChiInsiderSell17,303$27.97$483,964.91 12/20/2024Oluyemi OkupeCFOSell18,959$25.77$488,573.43 12/19/2024Michael ChiInsiderSell7,500$26.00$195,000.00 12/16/2024Andrew DudumCEOSell78,127$29.62$2,314,121.74 12/16/2024Irene BecklundInsiderSell472$29.58$13,961.76 12/10/2024Melissa BairdCOOSell85,561$31.01$2,653,246.61 12/10/2024Michael ChiInsiderSell7,259$32.25$234,102.75 12/2/2024Andrew DudumCEOSell33,513$33.38$1,118,663.94 12/2/2024Michael ChiInsiderSell2,054$33.56$68,932.24 11/26/2024Soleil BoughtonInsiderSell2,343$29.90$70,055.70 11/25/2024Oluyemi OkupeCFOSell101,993$29.62$3,021,032.66 11/18/2024Irene BecklundInsiderSell472$19.42$9,166.24 11/18/2024Melissa BairdCOOSell58,750$21.04$1,236,100.00 11/14/2024Anja ManuelDirectorBuy1,000$24.50$24,500.00 11/13/2024Oluyemi OkupeCFOSell142,886$29.93$4,276,577.98 11/12/2024Anja ManuelDirectorBuy4,000$26.94$107,760.00 11/6/2024Patrick Harrison CarrollInsiderSell15,000$22.07$331,050.00 11/5/2024Andrew DudumCEOSell188,888$20.88$3,943,981.44 10/29/2024Soleil BoughtonInsiderSell2,339$23.16$54,171.24 10/25/2024Michael ChiInsiderSell17,304$22.00$380,688.00 10/21/2024Michael ChiInsiderSell7,500$22.20$166,500.00 10/15/2024Soleil BoughtonInsiderSell2,339$20.41$47,738.99 Important: case study on TGT (Ad)Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!Tap here to catch the TGT case study and learn more10/14/2024Oluyemi OkupeCFOSell269,739$20.31$5,478,399.09 10/7/2024Melissa BairdCOOSell58,750$19.57$1,149,737.50 10/7/2024Oluyemi OkupeCFOSell9,868$19.96$196,965.28 9/20/2024Andrew DudumCEOSell45,767$16.33$747,375.11 9/20/2024Oluyemi OkupeCFOSell12,651$16.79$212,410.29 9/17/2024Soleil BoughtonInsiderSell2,339$16.50$38,593.50 9/4/2024Melissa BairdCOOSell11,749$14.65$172,122.85 9/3/2024Andrew DudumCEOSell188,888$14.56$2,750,209.28 9/3/2024Oluyemi OkupeCFOSell11,609$14.60$169,491.40 9/3/2024Soleil BoughtonInsiderSell2,345$14.65$34,354.25 8/27/2024Christiane PendarvisDirectorSell7,000$15.15$106,050.00 8/16/2024Irene BecklundInsiderSell472$15.66$7,391.52 8/6/2024Melissa BairdCOOSell16,784$17.00$285,328.00 8/6/2024Soleil BoughtonInsiderSell2,334$17.30$40,378.20 8/5/2024Andrew DudumCEOSell188,888$16.47$3,110,985.36 8/1/2024Michael ChiInsiderSell2,054$22.00$45,188.00 7/23/2024Soleil BoughtonInsiderSell2,335$20.29$47,377.15 7/16/2024Irene BecklundInsiderSell472$23.23$10,964.56 7/12/2024Michael ChiInsiderSell9,313$22.00$204,886.00 7/9/2024Melissa BairdCOOSell17,625$20.42$359,902.50 7/9/2024Soleil BoughtonInsiderSell2,335$20.28$47,353.80 7/5/2024Melissa BairdCOOSell17,625$20.51$361,488.75 7/3/2024Andrew DudumCEOSell188,888$20.75$3,919,426.00 6/25/2024Oluyemi OkupeCFOSell11,546$22.21$256,436.66 6/24/2024Michael ChiInsiderSell17,303$22.07$381,877.21 6/20/2024Andrew DudumCEOSell45,755$22.97$1,050,992.35 6/20/2024Michael ChiInsiderSell7,500$24.50$183,750.00 6/17/2024Irene BecklundInsiderSell472$24.10$11,375.20 6/6/2024Oluyemi OkupeCFOSell98,635$21.42$2,112,761.70 6/4/2024Andrew DudumCEOSell188,888$19.88$3,755,093.44 6/4/2024Melissa BairdCOOSell17,625$20.42$359,902.50 5/30/2024Soleil BoughtonInsiderSell129,667$20.55$2,664,656.85 5/28/2024Soleil BoughtonInsiderSell2,502$17.33$43,359.66 5/22/2024Christopher D PayneDirectorBuy110,000$17.74$1,951,763.00 5/20/2024Soleil BoughtonInsiderSell4,915$20.01$98,349.15 5/17/2024Irene BecklundinsiderSell943$14.50$13,673.50 5/13/2024Christiane PendarvisDirectorSell4,000$12.33$49,320.00 5/13/2024Soleil BoughtonInsiderSell2,503$12.33$30,861.99 5/9/2024Patrick Harrison CarrollInsiderSell10,000$13.00$130,000.00 5/2/2024Melissa BairdCOOSell11,750$12.08$141,940.00 5/1/2024Andrew DudumCEOSell188,888$12.54$2,368,655.52 4/29/2024Soleil BoughtonInsiderSell2,503$12.56$31,437.68 4/15/2024Soleil BoughtonInsiderSell2,503$13.95$34,916.85 4/8/2024Melissa BairdCOOSell11,751$14.74$173,209.74 4/5/2024Melissa BairdCOOSell11,751$14.58$171,329.58 4/4/2024Andrew DudumCEOSell188,888$14.97$2,827,653.36 4/1/2024Soleil BoughtonInsiderSell2,503$15.65$39,171.95 3/20/2024Andrew DudumCEOSell50,361$16.34$822,898.74 3/20/2024Oluyemi OkupeCFOSell9,912$15.82$156,807.84 3/19/2024Lynne Chou O'keefeDirectorSell10,044$15.52$155,882.88 Critical ‘Buy Now’ Alert on My Favorite Stock! (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>>3/18/2024Irene BecklundInsiderSell472$14.70$6,938.40 3/13/2024Soleil BoughtonInsiderSell63,621$15.17$965,130.57 3/7/2024Irene BecklundInsiderSell2,747$14.19$38,979.93 3/6/2024Melissa BairdCOOSell11,751$13.99$164,396.49 2/27/2024Irene BecklundInsiderSell2,747$12.08$33,183.76 (Data available from 1/1/2013 forward) HIMS Insider Trading Activity - Frequently Asked Questions Who is on Hims & Hers Health's Insider Roster? The list of insiders at Hims & Hers Health includes Alex Bard, Andrew Dudum, Anja Manuel, Christiane Pendarvis, Christopher D Payne, David B Wells, Irene Becklund, Jules A Maltz, Lynne Chou O'keefe, Melissa Baird, Michael Chi, Oluyemi Okupe, Patrick Harrison Carroll, and Soleil Boughton. Learn more on insiders at HIMS. What percentage of Hims & Hers Health stock is owned by insiders? 17.71% of Hims & Hers Health stock is owned by insiders. Learn more on HIMS's insider holdings. Which Hims & Hers Health insiders have been buying company stock? The following insiders have purchased HIMS shares in the last 24 months: Anja Manuel ($132,260.00), and Christopher D Payne ($1,951,763.00). How much insider buying is happening at Hims & Hers Health? Insiders have purchased a total of 115,000 HIMS shares in the last 24 months for a total of $2,084,023.00 bought. Which Hims & Hers Health insiders have been selling company stock? The following insiders have sold HIMS shares in the last 24 months: Alex Bard ($5,775,000.00), Andrew Dudum ($45,402,510.70), Christiane Pendarvis ($155,370.00), David B Wells ($977,000.00), Irene Becklund ($632,300.17), Lynne Chou O'keefe ($634,057.88), Melissa Baird ($14,082,512.99), Michael Chi ($3,370,206.76), Oluyemi Okupe ($18,480,181.56), Patrick Harrison Carroll ($461,050.00), and Soleil Boughton ($14,931,894.07). How much insider selling is happening at Hims & Hers Health? Insiders have sold a total of 5,358,273 Hims & Hers Health shares in the last 24 months for a total of $104,902,084.13 sold. Hims & Hers Health Key ExecutivesMr. Andrew Dudum (Age 35)Co-Founder, Chairman & CEO Compensation: $1.98M10 recent tradesMr. Yemi Okupe (Age 38)Chief Financial Officer Compensation: $1.01M11 recent tradesMs. Melissa Baird (Age 46)Chief Operating Officer Compensation: $1.05M6 recent tradesMs. Soleil Teubner Boughton (Age 45)Chief Legal Officer & Corporate Secretary Compensation: $928.7kDr. Patrick Carroll M.D. (Age 66)Chief Medical Officer, Member of Medical Advisory Board & Director Compensation: $54kMr. Mike Chi (Age 44)Chief Commercial Officer Compensation: $998kMs. Irene A. Becklund (Age 39)Senior VP, Controller & Principal Accounting Officer Compensation: $361.12k2 recent tradesMs. Khobi BrooklynChief Communications OfficerMs. Amee ParekhSenior Vice President of Human ResourcesDr. Peter Stahl M.D.Senior VP & Member of Medical Advisory Board More Insider Trading Tools from MarketBeat Related Companies NTRA Insider Trading FMS Insider Trading GH Insider Trading OPCH Insider Trading RDNT Insider Trading BTSG Insider Trading SHC Insider Trading SGRY Insider Trading VCYT Insider Trading LFST Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NYSE:HIMS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
